Company Cizzle Biotechnology Holdings Plc
Equities
PSL
GB00BNG2VN02
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.675 GBX | -.--% | -1.47% | -14.10% |
Apr. 30 | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down | AN |
Apr. 30 | Cizzle Biotechnology Holdings Plc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nigel Lee
DFI | Director of Finance/CFO | 63 | 21-05-13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Dawn Coverley
BRD | Director/Board Member | 59 | 21-05-13 |
Nigel Lee
DFI | Director of Finance/CFO | 63 | 21-05-13 |
John Treacy
BRD | Director/Board Member | 42 | 19-01-28 |
Allan Syms
CHM | Chairman | 67 | 19-05-20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 396,391,773 | 237,343,096 ( 59.88 %) | 0 | 59.88 % |
Company contact information
Cizzle Biotechnology Holdings Plc
60 Gracechurch Street 6th Floor
EC3V 0HR, London
+44 20 7469 0930
http://www.cizzlebiotechnology.comSector
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-14.10% | 8.45M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- PSL Stock
- Company Cizzle Biotechnology Holdings Plc